摘要背景: 研究对中国2 型糖尿病患者在常规治疗的基础上加用阿卡波糖后对患者粪便肠道菌群
及血清炎症因子的影响. 方法: 95 名2 型糖尿病患者在常规治疗的基础上随机分为两组, A 组59 …

The aim of this research was to reveal the characteristics of gut microbiome altered by
acarbose intervention in Japanese patients with type 2 diabetes (T2D) and its possible …

Background: The connection between gut microbiota and metabolism and its role in the
pathogenesis of diabetes are increasingly recognized. The objective of this study was to …

Introduction The α-glucosidase inhibitor acarbose is an efficacious medicine for the
treatment and prevention of type 2 diabetes mellitus (T2DM). However, the response of gut …

OBJECTIVE Mounting evidence indicates that the gut microbiota are an important modifier of
obesity and diabetes. However, so far there is no information on gut microbiota and “live gut …

Aims To investigate whether microbial dysbiosis is associated with T1D in Chinese
population and to explore relationships between the composition of gut microbiome and …

Objective This study aimed to investigate the changes in inflammatory biomarkers between
newly diagnosed type 2 diabetes (T2DM) patients under one-year acarbose treatments and …

Background. More and more studies focus on the relationship between the gastrointestinal
microbiome and type 2 diabetes, but few of them have actually explored the relationship …

Objective Recent studies have demonstrated that gut microbiota was closely related to
metabolic disorders such as type 2 diabetes. Oral antidiabetic medications including …

Objectives Gut microbiota dysbiosis is known to be associated with diabetes; however, the
findings of previous studies are conflicting. To clarify the association between type 2 …